Scleraxis lentivirus-transfected human amniotic mesenchymal
stem cells promote tendon-bone healing in rabbits

doi:10.3969/j.issn.2095-4344.1867

Abstract

Abstract:

BACKGROUND: Human amniotic mesenchymal stem cells have a wide variety of sources, low immunogenicity, and multilineage differentiation potential. Studies have confirmed that Scleraxis gene can induce human amniotic mesenchymal stem cells to differentiate into ligaments and accelerate tendon-bone healing.

OBJECTIVE: To explore whether Scleraxis induces human amniotic mesenchymal stem cells to promote tendon-bone healing in vivo in rabbits, providing new options for clinical treatment of tendon-bone healing.

METHODS: The study protocol was approved by the Ethic Committee of the Affiliated Hospital of Zunyi Medical University, and written informed consent was obtained from each puerpera. The healthy full-term maternal placenta was taken and cultured, and human amniotic mesenchymal stem cells were isolated and cultured by trypsin digestion twice. Then the morphology of the cells was observed under an inverted microscope, and the cells were further cultured until the third generation for subsequent experiments. The lentivirus carrying the Scleraxis gene was transfected into human amniotic mesenchymal stem cells in vitro. Expression levels of ligament-related genes were detected by real-time fluorescent quantitative PCR, and the expression levels of related proteins were detected by immunofluorescence. Human amniotic mesenchymal stem cells transfected with Scleraxis gene were injected into the extraarticular tendon-bone model of rats. After 3 months, specimens were taken to observe the tendon-bone healing.

RESULTS AND CONCLUSION: (1) Human amniotic mesenchymal stem cells from passage to third generation showed long fusiform and vortex-like adherent growth under the inverted phase contrast microscope. (2) The third-generation human amniotic mesenchymal stem cells expressed green fluorescence after 24 hours of infection with the Scleraxis gene lentivirus, and the fluorescence expression was strong and stable. (3) Cell counting kit-8 findings indicated that lentivirus transfection of Scleraxis gene showed no influence on the cell growth rate. (4) Real-time fluorescent quantitative PCR findings showed that the mRNA expression of Scleraxis and ligament-related genes type I collagen, type III collagen, Fibronectin and Tenascin-C was significantly increased after lentivirus transfection of Scleraxis gene. (5) The results of immunofluorescence showed that the expression levels of ligament-related proteins type I collagen, type III collagen, Fibronectin and Tenascin-C were increased after lentivirus transfection of Scleraxis gene. To conclude, in vivo animal experiments have confirmed that the lentivirus transfection of Scleraxis gene can accelerate the tendon-bone healing of the rabbit extraarticular tendon-bone model.

Key words: human amniotic mesenchymal stem cells, Scleraxis, gene transfection, lentivirus, tendon-bone healing, tissue engineering

CLC Number:

Zou Gang, Zhang Jun, You Qi, Tang Jingfeng, Jin Ying, Yang Jibin, Zhu Xizhong, Liu Yi. Scleraxis lentivirus-transfected human amniotic mesenchymal stem cells promote tendon-bone healing in rabbits[J]. Chinese Journal of Tissue Engineering Research, 2020, 24(13): 2080-2086.

Figures/Tables 8

References

[1] RALLES S, AGEL J, OBERMEIER M, et al. Incidence of Secondary Intra-articular Injuries With Time to Anterior Cruciate Ligament Reconstruction. Am J Sports Med. 2015;43(6): 1373-1379.
[2] ATESOK K, FU FH, WOLF MR, et al. Augmentation of tendon-to- bone healing. J Bone Joint Surg Am. 2014;96(6):513-521.
[3] BALDINO L, CARDEA S, MAFFULLI N, et al. Regeneration techniques for bone-to-tendon and muscle-to-tendon interfaces reconstruction. Br Med Bull. 2016;117(1):25-37.
[4] BUNKER DL, ILIE V, ILIE V, et al. Tendon to bone healing and its implications for surgery. Muscles Ligaments Tendons J. 2014;4(3): 343-350.
[5] COTTRELL JA, TURNER JC, ARINZEH TL, et al. The Biology of Bone and Ligament Healing. Foot Ankle Clin. 2016;21(4):739-761.
[6] CARLBERG AL, TUAN RS, HALL DJ. Regulation of scleraxis function by interaction with the bHLH protein E47. Mol Cell Biol Res Commun. 2000;3(2):82-86.
[7] HU JS, OLSON EN, KINGSTON RE. HEB, a helix-loop-helix protein related to E2A and ITF2 that can modulate the DNA-binding ability of myogenic regulatory factors. Mol Cell Biol. 1992;12(3): 1031-1042.
[8] LIU Y, WATANABE H, NIFUJI A, et al. Overexpression of a single helix-loop-helix-type transcription factor, scleraxis, enhances aggrecan gene expression in osteoblastic osteosarcoma ROS17/2.8 cells. J Biol Chem. 1997;272(47):29880-29885.
[9] ALBERTON P, POPOV C, PRÄGERT M, et al. Conversion of human bone marrow-derived mesenchymal stem cells into tendon progenitor cells by ectopic expression of scleraxis. Stem Cells Dev. 2012;21(6):846-858.
[10] MADRY H, KOHN D, CUCCHIARINI M. eDirect FGF-2 gene transfer via recombinant adeno-associated virus vectors stimulates cell proliferation, collagen production, and the repair of experimental lesions in the human ACL. Am J Sports Med. 2013; 41(1):194-202.
[11] WANG CJ, WENG LH, HSU SL, et al. pCMV-BMP-2-transfected cell-mediated gene therapy in anterior cruciate ligament reconstruction in rabbits. Arthroscopy. 2010;26(7):968-976.
[12] CHEN B, LI B, QI YJ, et al. Enhancement of tendon-to-bone healing after anterior cruciate ligament reconstruction using bone marrow-derived mesenchymal stem cells genetically modified with bFGF/BMP2. Sci Rep. 2016;6:25940.
[13] KAWAKAMI Y, TAKAYAMA K, MATSUMOTO T, et al. Anterior Cruciate Ligament-Derived Stem Cells Transduced With BMP2 Accelerate Graft-Bone Integration After ACL Reconstruction. Am J Sports Med. 2017;45(3):584-597.
[14] PENG W, ZHANG J, ZHANG H, et al. Effects of lentiviral transfection containing bFGF gene on the biological characteristics of rabbit BMSCs. J Cell Biochem. 2018;119(10): 8389-8397.
[15] 周文然,李新,王文波,等.人羊膜间充质干细胞生物学特征及向多巴胺能神经元样细胞的分化[J].中国组织工程研究,2014,18(23): 3682-3690.
[16] MAIDHOF R, RAFIUDDIN A, CHOWDHURY F, et al. Timing of mesenchymal stem cell delivery impacts the fate and therapeutic potential in intervertebral disc repair. J Orthop Res. 2017;35(1): 32-40.
[17] NOGAMI M, KIMURA T, SEKI S, et al. A Human Amnion-Derived Extracellular Matrix-Coated Cell-Free Scaffold for Cartilage Repair: In Vitro and In Vivo Studies. Tissue Eng Part A. 2016; 22(7-8):680-688.
[18] 洪佳琼,高雅,宋洁,等.人羊膜间充质干细胞与骨髓间充质干细胞的生物学特性及免疫抑制作用的比较[J].中国实验血液学杂志, 2016, 24(3):858-864.
[19] LI Y, LIU Z, JIN Y, et al. Differentiation of Human Amniotic Mesenchymal Stem Cells into Human Anterior Cruciate Ligament Fibroblast Cells by In Vitro Coculture. Biomed Res Int. 2017;2017: 7360354.
[20] 邹刚,李豫皖,金瑛,等.TGF-β1联合VEGF对人羊膜间充质干细胞向韧带成纤维细胞体外分化作用的研究[J].中国修复重建外科杂志, 2017,31(5): 582-591.
[21] 李豫皖,朱喜忠,金瑛,等.体外定向诱导人羊膜间充质干细胞向骨、软骨及脂肪细胞的分化[J].中国组织工程研究,2017,21(1):122-127.
[22] 朱喜忠,刘子铭,吴术红,等.Scleraxis慢病毒基因感染人羊膜间充质干细胞向肌腱细胞的定向分化[J].中国组织工程研究,2017,21(33): 5382-5387.
[23] HONG Y. ACL injury: incidences, healing, rehabilitation, and prevention: part of the Routledge Olympic special issue collection. Res Sports Med. 2012;20(3-4):155-156.
[24] ZAFFAGNINI S, SIGNORELLI C, BONANZINGA T, et al. Technical variables of ACL surgical reconstruction: effect on post-operative static laxity and clinical implication. Knee Surg Sports Traumatol Arthrosc. 2016;24(11):3496-3506.
[25] AHN JH, LEE YS, KO TS, et al. Accuracy and Reproducibility of the Femoral Tunnel With Different Viewing Techniques in the ACL Reconstruction. Orthopedics. 2016;39(6):e1085-e1091.
[26] SCHWEITZER R, CHYUNG JH, MURTAUGH LC, et al. Analysis of the tendon cell fate using Scleraxis, a specific marker for tendons and ligaments. Development. 2001;128(19):3855-3866.
[27] CSERJESI P, BROWN D, LIGON KL, et al. Scleraxis: a basic helix-loop-helix protein that prefigures skeletal formation during mouse embryogenesis. Development.1995;121(4):1099-1110.
[28] PRYCE BA, BRENT AE, MURCHISON ND, et al. Generation of transgenic tendon reporters, ScxGFP and ScxAP, using regulatory elements of the scleraxis gene. Dev Dyn. 2007;236(6):1677-1682.
[29] MENDIAS CL, GUMUCIO JP, BAKHURIN KI, et al. Physiological loading of tendons induces scleraxis expression in epitenon fibroblasts. J Orthop Res. 2012;30(4):606-612.
[30] MURCHISON ND, PRICE BA, Conner DA, et al. Regulation of tendon differentiation by scleraxis distinguishes force-transmitting tendons from muscle-anchoring tendons. Development. 2007; 134(14): 2697-2708.
[31] ALBERTON P, POPOV C, PRÄGERT M, et al. Conversion of human bone marrow-derived mesenchymal stem cells into tendon progenitor cells by ectopic expression of scleraxis. Stem Cells Dev. 2012;21(6): 846-858.
[32] GULOTTA LV, RODEO SA. Emerging ideas: Evaluation of stem cells genetically modified with scleraxis to improve rotator cuff healing. Clin Orthop Relat Res. 2011;469(10):2977-2980.
[33] GULOTTA LV, KOVACEVIC D, Packer JD, et al. Bone marrow-derived mesenchymal stem cells transduced with scleraxis improve rotator cuff healing in a rat model. Am J Sports Med. 2011;39(6): 1282-1289.
[34] CAI J, WANG J, YE K, et al. Dual-layer aligned-random nanofibrous scaffolds for improving gradient microstructure of tendon-to-bone healing in a rabbit extra-articular model. Int J Nanomedicine. 2018;13:3481-3492.
[35] ZHANG P, ZHI Y, FANG H, et al. Effects of polyvinylpyrrolidone- iodine on tendon-bone healing in a rabbit extra-articular model. Exp Ther Med. 2017;13(6):2751-2756.
[36] LI H, GE Y, WU Y, et al. Hydroxyapatite coating enhances polyethylene terephthalate artificial ligament graft osseointegration in the bone tunnel. Int Orthop. 2011;35(10): 1561-1567.
[37] ZHI Y, LIU W, ZHANG P, et al. Electrospun silk fibroin mat enhances tendon-bone healing in a rabbit extra-articular model. Biotechnol Lett. 2016;38(10):1827-1835.